Martha Sajatovic, MD
Department of Psychiatry
Case Western Reserve University School of Medicine
Director, Geriatric Psychiatry Research
University Hospitals Case Medical Center
Mark Robert Rosenberg, MD, PhD
President, Behavioral Health Management, PC
THIS PROGRAM WAS ORIGINALLY RELEASED AS A LIVE AUDIOCONFERENCE SERIES BEGINNING ON JUNE 13, 2007. IF YOU RECEIVED CME OR CPE CREDIT FOR THE AUDIOCONFERENCE, YOU ARE NOT ELIGIBLE TO RECEIVE CREDIT FOR THIS ONLINE VERSION.
This is the second program in a two-part series.
Bipolar disorder (BPD) is a recurrent and often long-term psychiatric condition that adversely affects the lives of persons with BPD and their families. It is also the most expensive behavioral health diagnosis for both individuals and their insurance providers. Due to the chronic nature of BPD, persistent treatment is often required for maintenance. However individuals with BPD often find it difficult to comply with their medication regimens. As a result, absenteeism and lost productivity are growing to appalling proportions as persons with BPD experience unmanaged mania and depression.
This activity provides an overview of the economic burden of BPD with the goal of providing practical information for managed care providers. The identifying features of BPD are outlined to distinguish BPD from unipolar depression. The challenges of long-term maintenance treatment and treatment strategies are discussed with an emphasis on improving adherence to therapy.
. Target Audience
Managed Care Medical Directors, Pharmacy Directors, Physicians, and Pharmacists
Upon completion of this educational activity, the participant should be able to:
Describe the economic impact of poor therapy adherence on the healthcare system.
Review the importance of long-term maintenance treatment for bipolar disorder.
Discuss the importance of correctly diagnosing bipolar depression vs unipolar depression and the relevance to long-term outcomes and economic impact.
Compare current and new pharmacotherapy indicated for bipolar disorder.
Summarize ways to improve patient adherence to pharmacologic and behavioral therapies.
Martha Sajatovic, MD has received research grants from Bristol-Myers Squibb and Abbott Laboratories, is a consultant for AstraZeneca and GlaxoSmithKline, and has received honoraria from AstraZeneca.
Mark Rosenberg, MD has no financial interests to disclose. Credit Statements
Physicians: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the National Association of Managed Care Physicians (NAMCP) and Medical Communications Media, Inc. The NAMCP is accredited by the ACCME to provide continuing medical education to physicians.
NAMCP designates this continuing medical education activity for a maximum of 1 AMA PRA Category I credit TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pharmacists: ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Program Numbers 221-999-07-051-H01-P/221-999-07-051-H01-T have been assigned to this program (initial release date September 24, 2007). This program is approved for 1.0 contact hours (0.10 CEUs) in states that recognize ACPE providers. The program is provided at no cost to participants. Participants must pass the post-test with a score of 70% or higher and complete the program evaluation to receive pharmacy CE credit. No partial credit will be given. Commercial Support Statements
Supported by an educational grant from AstraZeneca.
Please turn off all pop-up blockers.
Click on the “start program” icon. This will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or update/correct existing registration information. When ready, click on the “continue to program” icon at the bottom of the screen. This will take you to a brief pre-program survey.
The next screen will permit you to check for or download the Flash player required to run this program.
Clicking “start the virtual meeting” will allow you to begin the program presentation. This activity will require approximately 60 minutes to complete.
Upon completion of the program, click on the post-test button to access the post-test and program evaluation. This will bring you to a brief post-program survey.
Instructions for completing and submitting the post-test are provided on the post-test screen. A minimum score of 70% on the post-test is required for a CME/CPE statement of credit. Two attempts are allowed.
©2007, Medical Communications Media, Inc. All Rights Reserved.
None of the contents may be reproduced in any form without prior written permission of the publisher. The opinions expressed in this activity are those of the speakers and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the National Association of Managed Care Physicians or AstraZeneca. Any medications or other diagnostic or treatment procedures discussed by the program speakers should not be utilized by clinicians without evaluation of their patients’ conditions and of possible contraindications or risks, and without a review of any applicable manufacturer’s product information and comparison with the recommendations of other authorities.